Does Rallies show 13F holders for OMCL?

Yes. Rallies tracks hedge fund and 13F ownership data for OMCL, including fund names, share counts, latest tracked quarter, and position changes when available.

Is OMCL research on Rallies investment advice?

No. Rallies provides research, data, and educational context for OMCL. It does not provide personalized investment advice.

OMCL (Omnicell Inc) Stock Analysis - Hedge Fund Holdings

Omnicell Inc (OMCL) is a publicly traded Healthcare sector company. As of May 21, 2026, OMCL trades at $44.42 with a market cap of $1.97B and a P/E ratio of 101.06. OMCL moved +2.07% today. Year to date, OMCL is -4.71%; over the trailing twelve months it is +55.39%. Its 52-week range spans $22.66 to $55.75. Analyst consensus is strong buy with an average price target of $59.80. Rallies surfaces OMCL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns OMCL stock?

Hedge funds tracked by Rallies that own OMCL include Panagora Asset, Centerbook Partners, and Bridgewater Associates. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Omnicell Inc.

OMCL Key Metrics

Key financial metrics for OMCL
Metric	Value
Price	$44.42
Market Cap	$1.97B
P/E Ratio	101.06
EPS	$0.44
Dividend Yield	0.00%
52-Week High	$55.75
52-Week Low	$22.66
Volume	2
Avg Volume	0
Revenue (TTM)	$1.23B
Net Income	$20.43M
Gross Margin	43.50%

Top Hedge Funds Holding OMCL

Panagora Asset holds 263.50K shares of OMCL, changed +24.99% as of Mar 31, 2026.
Centerbook Partners holds 20.25K shares of OMCL, changed +138.62% as of Mar 31, 2026.
Bridgewater Associates holds 4.96K shares of OMCL, changed -72.34% as of Dec 31, 2024.

Latest OMCL News

Omnicell Sees 15% Q1 Revenue Growth, Swings to Profit and Raises 2026 Outlook — Apr 28, 2026
Omnicell Targets $2.4B Revenue by 2031 Through High-Margin SaaS Strategy — Feb 28, 2026
Omnicell Q4 EPS Misses by $0.07, Revenue Up 2.3%, Raises FY26 Guidance — Feb 6, 2026
Omnicell Reports Q4 Revenue Growth of 2% to $314M, Unveils Titan XT — Feb 6, 2026
Zacks Upgrades Omnicell to Buy; Q4 and Full-Year 2025 Results Set Feb. 5 Release — Jan 13, 2026

Recent OMCL Insider Trades

Manley Corey J sold 7.41K (~$256.88K) on Mar 16, 2026.
Manley Corey J sold 4.24K (~$155.25K) on Feb 17, 2026.
Manley Corey J sold 6.11K (~$304.69K) on Jan 8, 2026.

OMCL Analyst Consensus

6 analysts cover OMCL: 0 strong buy, 5 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $59.80.

Common questions about OMCL

Who owns OMCL stock?: Hedge funds tracked by Rallies that own OMCL include Panagora Asset, Centerbook Partners, and Bridgewater Associates. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Omnicell Inc.
Does Rallies show 13F holders for OMCL?: Yes. Rallies tracks hedge fund and 13F ownership data for OMCL, including fund names, share counts, latest tracked quarter, and position changes when available.
Is OMCL research on Rallies investment advice?: No. Rallies provides research, data, and educational context for OMCL. It does not provide personalized investment advice.